TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team

Company Overview - TRxADE Health, Inc. has appointed Narasimhan Mani, Ph.D., MBA as President of its subsidiary Scienture, LLC, while Shankar Hariharan, Ph.D., continues as CEO of Scienture [1][3] - Rahul Surana, Ph.D., MBA has been promoted to Executive VP and COO of Scienture, recognizing his significant contributions since the company's inception [1][3] Leadership Experience - Dr. Narasimhan Mani brings over 25 years of experience in the pharmaceutical industry, having held leadership roles in various companies including Kesin Pharma Corporation and Xiromed LLC [2] - Shankar Hariharan, the current CEO, has over 37 years of experience in the pharmaceutical sector, with a history of leading successful branded, specialty, and generic pharmaceutical businesses [3] Strategic Direction - The appointment of Dr. Mani is seen as a strategic move to enhance Scienture's capabilities in Finance, Business Strategy, and Commercial Operations, particularly as the company prepares for upcoming launches of its specialty portfolio [3] - Scienture recently completed a business combination with TRxADE Health, Inc. valued at $103 million, indicating a significant step in its growth strategy [4] Company Focus - Scienture is a New York-based branded specialty pharmaceutical company focused on developing unique specialty product concepts that provide enhanced value to patients and healthcare systems [4] - TRxADE Health, Inc. primarily operates through its subsidiary Integra Pharma Solutions, which is a licensed pharmaceutical wholesaler serving various healthcare markets [5]